SavedAdd your journal

Journals / Molecular Imaging and Radionuclide Therapy / 2021 / Cilt: 30 - Sayı: 3

F-Sodium Fluoride (NaF) Uptake in Calcified Bladder Carcinoma: Double Density Sign

Kalsifiye Mesane Karsinomunda 18F-Sodyum Florür (NaF) Tutulumu: Çift Yoğunluk İşareti

Kalsifiye Mesane KARSINOMUNDA
Najeeb AHMED
Pages
190–192
Publication Date
2022-09-03
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Thus, recognition of extraosseous 18F-NaF activity has implications for accurate staging and management.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:18F-Sodium fluoride (NaF) is primarily a skeletal imaging agent which can be localized in extraosseous calcified foci.
📊
Key Findings & Data:Here, we describe a case of a 48-year-old man with bladder carcinoma referred for staging using 18F-NaF positron emission tomography/computed tomography (PET/CT). 18F-NaF PET/CT detected a calcified soft tissue mass in the urinary bladder.
💡
Conclusion & Impact:Thus, recognition of extraosseous 18F-NaF activity has implications for accurate staging and management.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

18F-Sodium fluoride (NaF) is primarily a skeletal imaging agent which can be localized in extraosseous calcified foci. Here, we describe a case of a 48-year-old man with bladder carcinoma referred for staging using 18F-NaF positron emission tomography/computed tomography (PET/CT). 18F-NaF PET/CT detected a calcified soft tissue mass in the urinary bladder. Extraosseous 18F-NaF uptake is often encountered and these nonosseous findings could possibly provide important diagnostic information. Thus, recognition of extraosseous 18F-NaF activity has implications for accurate staging and management.

Özet

Öncelikle bir iskelet sistemi görüntüleme ajanı olan 18F-Sodyum Florür (NaF) ekstraosseöz kalsifiye odaklarda da tutulum gösterebilir. Burada, 18F -NaF pozitron emisyon tomografisi/bilgisayarlı tomografi (PET/BT) kullanılarak evreleme için sevk edilen mesane karsinomu tanılı 48 yaşında bir erkek olgu sunulmuştur. 18F- NaF PET/BT ile, idrar kesesinde kalsifiye yumuşak doku kitlesi tespit edilmiştir. Ekstraosseöz 18F-NaF tutulumuna sıklıkla rastlanır ve bu kemik dışı bulgular önemli tanısal bilgiler sağlayabilir. Bu nedenle, ekstraosseöz 18F-NaF aktivitesinin tanınmasının doğru evreleme ve tedavi açısından önemli etkileri vardır.

🔖

Cite This Article

KARSINOMUNDA, K. M., AHMED, N. (2022). F-Sodium Fluoride (NaF) Uptake in Calcified Bladder Carcinoma: Double Density Sign. Molecular Imaging and Radionuclide Therapy, Cilt: 30 - Sayı: 3, 190–192. https://ajindex.com/articles/425722

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016;66:7-30
  2. Babaian RJ, Johnson DE, Llamas L, Ayala AG. Metastases from transitional cell carcinoma of urinary bladder. Urology 1980;16:142-144
  3. Kirkali Z, Chan T, Manoharan M, Algaba F, Busch C, Cheng L, Kiemeney L, Kriegmair M, Montironi R, Murphy WM, Sesterhenn IA, Tachibana M, Weider J. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 2005;66(6 Suppl 1):4-34
  4. Czernin J, Satyamurthy N, Schiepers C. Molecular mechanisms of bone 18F-NaF deposition. J Nucl Med 2010;51:1826-1829
  5. Araz M, Aras G, Küçük ÖN. The role of 18F-NaF PET/CT in metastatic bone disease. J Bone Oncol 2015;4:92-97
  6. Usmani S, Gnanasegaran G, Marafi F, Esmail A, Ahmed N, Van den Wyngaert T. The clinical significance of incidental soft tissue uptake on whole body 18F-sodium fluoride bone PET-CT. Clin Radiol 2019;74:95- 110
  7. Korkmaz U, Ustun F. 18F-NaF PET/CT and Extraordinary Involvement: Non-calcific Brain Involvement in a Prostate Cancer Case. Mol Imaging Radionucl Ther 2020;29:41-44
  8. Sheth S, Colletti PM. Atlas of sodium fluoride PET bone scans: atlas of NaF PET bone scans. Clin Nucl Med 2012;37:e110-116
  9. Van Der Gucht A, Galat A, Rosso J, Guellich A, Garot J, Bodez D, et al. [18F]-NaF PET/CT imaging in cardiac amyloidosis. J Nucl Cardiol 2016;23:846-849.